Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $60.3333.
IPX has been the subject of a number of research reports. Roth Mkm reaffirmed a “buy” rating on shares of IperionX in a research report on Monday, June 8th. BTIG Research raised their price objective on IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday, June 5th. Alliance Global Partners reiterated a “buy” rating on shares of IperionX in a report on Tuesday, April 28th. Weiss Ratings reissued a “sell (e+)” rating on shares of IperionX in a report on Tuesday, April 21st. Finally, B. Riley Financial cut their price target on IperionX from $58.00 to $52.00 and set a “buy” rating on the stock in a research report on Friday, March 13th.
View Our Latest Stock Analysis on IperionX
Insider Transactions at IperionX
Hedge Funds Weigh In On IperionX
Hedge funds and other institutional investors have recently made changes to their positions in the company. JPMorgan Chase & Co. acquired a new stake in shares of IperionX in the second quarter valued at about $66,000. State of Tennessee Department of Treasury acquired a new stake in shares of IperionX in the fourth quarter valued at approximately $119,000. Quadrature Capital Ltd lifted its position in IperionX by 42.8% during the fourth quarter. Quadrature Capital Ltd now owns 14,918 shares of the company’s stock worth $540,000 after buying an additional 4,471 shares in the last quarter. DV Equities LLC purchased a new position in IperionX during the fourth quarter worth approximately $178,000. Finally, Man Group plc acquired a new position in IperionX during the fourth quarter worth $257,000. Hedge funds and other institutional investors own 2.76% of the company’s stock.
IperionX Stock Performance
NASDAQ IPX opened at $28.78 on Friday. IperionX has a 12-month low of $21.66 and a 12-month high of $61.45. The company has a fifty day simple moving average of $34.77 and a two-hundred day simple moving average of $37.73. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03.
About IperionX
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high?purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Featured Articles
- Five stocks we like better than IperionX
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil JalapeƱo: An Early Step to Massive AI Growth Potential
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
